Relationship between frontostriatal morphology and executive function deficits in bipolar I disorder following a first manic episode: Data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM)

Bipolar Disorders

Volumn 15, Issue 6, 2013, Pages 657-668

  Kozicky, Jan Marie ^a   Ha, Tae Hyon ^a,b   Torres, Ivan J ^a,c   Bond, David J ^a   Honer, William G ^a   Lam, Raymond W ^a   Yatham, Lakshmi N ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Seoul National University Bundang Hospital   (South Korea)

^c Riverview Hospital   (Canada)

Author keywords

Basal ganglia; Bipolar disorder; CANTAB; Caudate; Cognition; Dorsolateral prefrontal cortex; Executive function; Magnetic resonance imaging; Voxel based morphometry

Indexed keywords

LITHIUM; OLANZAPINE; QUETIAPINE; RISPERIDONE; VALPROATE SEMISODIUM;

ADULT; ARTICLE; BIPOLAR I DISORDER; BRAIN SIZE; CAUDATE NUCLEUS; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; EXECUTIVE FUNCTION; FEMALE; HUMAN; INTELLIGENCE QUOTIENT; MALE; MANIA; MORPHOMETRICS; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PREFRONTAL CORTEX; PRIORITY JOURNAL; REMISSION; WORKING MEMORY;

BASAL GANGLIA; BIPOLAR DISORDER; CANTAB; CAUDATE; COGNITION; DORSOLATERAL PREFRONTAL CORTEX; EXECUTIVE FUNCTION; MAGNETIC RESONANCE IMAGING; VOXEL-BASED MORPHOMETRY;

ADOLESCENT; ADULT; BIPOLAR DISORDER; COGNITION DISORDERS; CORPUS STRIATUM; DISEASE PROGRESSION; EXECUTIVE FUNCTION; FEMALE; FRONTAL LOBE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; REGRESSION ANALYSIS; YOUNG ADULT;

EID: 84883559165     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/bdi.12103     Document Type: Article

References (84)

1. Martinez-Aran A, Vieta E, Reinares M et al. Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. Am J Psychiatry 2004; 161: 262-270.
2. Torres IJ, Boudreau VG, Yatham LN. Neuropsychological functioning in euthymic bipolar disorder: a meta-analysis. Acta Psychiatr Scand Suppl 2007; 434: 17-26.
3. Burgess PW, Shallice T. Response suppression, initiation and strategy use following frontal lobe lesions. Neuropsychologia 1996; 34: 263-272.
4. Simblett SK, Bateman A. Dimensions of the Dysexecutive Questionnaire (DEX) examined using Rasch analysis. Neuropsychol Rehabil 2011; 21: 1-25.
5. Wingo AP, Harvey PD, Baldessarini RJ. Neurocognitive impairment in bipolar disorder patients: functional implications. Bipolar Disord 2009; 11: 113-125.
6. Martinez-Aran A, Vieta E, Torrent C et al. Functional outcome in bipolar disorder: the role of clinical and cognitive factors. Bipolar Disord 2007; 9: 103-113.
7. Tohen M, Zarate CA, Hennen J et al. The McLean-Harvard first-episode mania study: prediction of recovery and first recurrence. Am J Psychiatry 2003; 160: 2099-2107.
8. Torres IJ, DeFreitas VG, DeFreitas CM et al. Neurocognitive functioning in patients with bipolar I disorder recently recovered from a first manic episode. J Clin Psychiatry 2010; 71: 1234-1242.
9. Barrett SL, Mulholland CC, Cooper SJ, Rushe TM. Patterns of neurocognitive impairment in first-episode bipolar disorder and schizophrenia. Br J Psychiatry 2009; 195: 67-72.
10. Savitz JB, van der Merwe L, Stein DJ, Solms M, Ramesar RS. Neuropsychological task performance in bipolar spectrum illness: genetics, alcohol abuse, medication and childhood trauma. Bipolar Disord 2008; 10: 479-494.
11. Gosso MF, de Geus EJC, Polderman TJC, Boomsma DI, Heutink P, Posthuma D. Catechol O-methyl transferase and dopamine D2 receptor gene polymorphisms: evidence of positive heterosis and gene-gene interaction on working memory functioning. Eur J Human Genet 2008; 16: 1075-1082.
12. Le-Niculescu H, McFarland MJ, Mamidipalli S et al. Convergent Functional Genomics of bipolar disorder: from animal model pharmacogenomics to human genetics and biomarkers. Neurosci Biobehav Rev 2007; 31: 897-903.
13. Arts B, Jabben N, Krabbendam L, van Os J. Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives. Psychol Med 2008; 38: 771-785.
14. Bora E, Yucel M, Pantelis C. Cognitive endophenotypes of bipolar disorder: a meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives. J Affect Disord 2009; 113: 1-20.
15. Elshahawi HH, Essawi H, Rabie MA, Mansour M, Beshry ZA, Mansour AN. Cognitive functions among euthymic bipolar I patients after a single manic episode versus recurrent episodes. J Affect Disord 2011; 130: 180-191.
16. Kapczinski F, Vieta E, Andreazza AC et al. Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neurosci Biobehav Rev 2008; 32: 675-692.
17. Arnsten AFT. Stress signalling pathways that impair prefrontal cortex structure and function. Nat Rev Neurosci 2009; 10: 410-422.
18. Donaldson S, Goldstein LH, Landau S, Raymont V, Frangou S. The Maudsley Bipolar Disorder Project: the effect of medication, family history, and duration of illness on IQ and memory in bipolar I disorder. J Clin Psychiatry 2003; 64: 86-93.
19. Frangou S, Donaldson S, Hadjulis M, Landau S, Goldstein LH. The Maudsley Bipolar Disorder Project: executive dysfunction in bipolar disorder I and its clinical correlates. Biol Psychiatry 2005; 58: 859-864.
20. Jamrozinski K, Gruber O, Kemmer C, Falkai P, Scherk H. Neurocognitive functions in euthymic bipolar patients. Acta Psychiatr Scand 2009; 119: 365-374.
21. Zimmerman ME, DelBello MP, Getz GE, Shear PK, Strakowski SM. Anterior cingulate subregion volumes and executive function in bipolar disorder. Bipolar Disord 2006; 8: 281-288.
22. Haldane M, Cunningham G, Androutsos C, Frangou S. Structural brain correlates of response inhibition in bipolar disorder I. J Psychopharmacol 2008; 22: 138-143.
23. Hartberg CB, Sundet K, Rimol LM et al. Subcortical brain volumes relate to neurocognition in schizophrenia and bipolar disorder and healthy controls. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35: 1122-1130.
24. O'Reilly RC, Herd SA, Pauli WM. Computational models of cognitive control. Curr Opin Neurobiol 2010; 20: 257-261.
25. Simpson EH, Kellendonk C, Kandel E. A possible role for the striatum in the pathogenesis of the cognitive symptoms of schizophrenia. Neuron 2010; 65: 585-596.
26. Marchand WR, Yurgelun-Todd D. Striatal structure and function in mood disorders: a comprehensive review. Bipolar Disord 2010; 12: 764-785.
27. Bennett MR. The prefrontal-limbic network in depression: modulation by hypothalamus, basal ganglia and midbrain. Prog Neurobiol 2011; 93: 468-487.
28. Chen C-H, Suckling J, Lennox BR, Ooi C, Bullmore ET. A quantitative meta-analysis of fMRI studies in bipolar disorder. Bipolar Disord 2011; 13: 1-15.
29. Liu IY, Howe M, Garrett A et al. Striatal volumes in pediatric bipolar patients with and without comorbid ADHD. Psychiatry Res 2011; 194: 14-20.
30. Noga JT, Vladar K, Torrey EF. A volumetric magnetic resonance imaging study of monozygotic twins discordant for bipolar disorder. Psychiatry Res 2001; 106: 25-34.
31. Bonelli RM, Kapfhammer HP, Pillay SS, Yurgelun-Todd DA. Basal ganglia volumetric studies in affective disorder: what did we learn in the last 15 years? J Neural Transm 2006; 113: 255-268.
32. Brooks JO, Bonner JC, Rosen AC et al. Dorsolateral and dorsomedial prefrontal grey matter density changes associated with bipolar depression. Psychiatry Res 2009; 172: 200-204.
33. Ekman CJ, Lind J, Ryden E, Ingvar M, Landen M. Manic episodes are associated with grey matter volume reduction - a voxel-based morphometry brain analysis. Acta Psychiatr Scand 2010; 122: 507-515.
34. Hafeman DM, Chang KD, Garrett AS, Sanders EM, Phillips ML. Effects of medication on neuroimaging findings in bipolar disorder: an updated review. Bipolar Disord 2012; 14: 375-410.
35. Robbins TW, James M, Owen AM et al. A study of performance on tests from the CANTAB battery sensitive to frontal lobe dysfunction in a large sample of normal volunteers: implications for theories of executive functioning and cognitive aging. J Int Neuropsychol Soc 1998; 4: 474-490.
36. Grahn JA, Parkinson JA, Owen AM. The cognitive functions of the caudate nucleus. Prog Neurobiol 2008; 86: 141-155.
37. Yatham LN, Kauer-Sant'Anna M, Bond DJ, Lam RW, Torres I. Course and outcome after the first manic episode in patients with bipolar disorder: prospective 12-month data from the Systematic Treatment Optimization Program for Early Mania Project. Can J Psychiatry 2009; 54: 105-112.
38. Sheehan DV, Lecrubier Y, Sheehan KH et al. The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59: 22-33.
39. Yatham LN, Kennedy SH, Schaffer A et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord 2009; 11: 225-255.
40. Baitz HA, Thornton AE, Procyshyn RM et al. Antipsychotic medications: linking receptor antagonism to neuropsychological functioning in first episode psychosis. J Int Neuropsychol Soc 2012; 18: 717-727.
41. Blair JR, Spreen O. Predicting premorbid IQ: a revision of the national adult reading test. Clin Neuropsychol 1989; 3: 129-136.
42. Kaufman AS, Kaufman NL. Kaufman Brief Intelligence Test Manual. Circle Pines, MN: American Guidance Service, Inc., 1990.
43. Statistical Parametric Mapping. London, UK: Wellcome Department of Imaging Neuroscience Group, 1994-2013. Available from: http://www.fil.ion.ucl.ac.uk/spm [accessed November 2011].
44. VBM8 Toolbox, 2011. Available from: http://dbm.neuro.uni-jena.de/vbm.html [accessed November 2011].
45. Ashburner J. A fast diffeomorphic image registration algorithm. Neuroimage 2007; 38: 95-113.
46. Dreganski B, Kehrif F, Kloppel S et al. Evidence for segregated and integrative connectivity patterns in the human basal ganglia. J Neurosci 2008; 28: 7143-7152.
47. Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH. An automated method for neuroanatomic and cytoarchitectonic atlas based interrogation of fMRI data sets. Neuroimage 2003; 19: 1233-1239.
48. Hammers A, Koepp MJ, Free SL et al. Implementation and application of a brain template for multiple volumes of interest. Hum Brain Mapp 2002; 15: 165-174.
49. Haber SN, Kim KS, Mailly P, Calzavara R. Reward-related cortical inputs define a large striatal region in primates that interface with associative cortical connections, providing a substrate for incentive-based learning. J Neurosci 2006; 26: 8368-8376.
50. Marchand WR. Cortico-basal ganglia circuitry: a review of key research and implications for functional connectivity studies of mood and anxiety disorders. Brain Struct Funct 2010; 215: 73-96.
51. Utter AA, Basso MA. The basal ganglia: an overview of circuits and function. Neurosci Biobehav Rev 2008; 32: 333-342.
52. Badre D, D'Esposito M. Is the rostro-caudal axis of the frontal lobe hierarchical? Nat Rev Neurosci 2009; 10: 659-669.
53. Adler CM, Holland SK, Schmithorst V, Tuchfarber MJ, Strakowski SM. Changes in neuronal activation in patients with bipolar disorder during performance of a working memory task. Bipolar Disord 2004; 6: 540-549.
54. Lennox BR, Jacob R, Calder AJ, Lupson V, Bullmore ET. Behavioural and neurocognitive responses to sad facial affect are attenuated in patients with mania. Psychol Med 2004; 34: 795-802.
55. Chen CH, Lennox B, Jacob R et al. Explicit and implicit facial affect recognition in manic and depressed states of bipolar disorder: a functional magnetic resonance imaging study. Biol Psychiatry 2006; 59: 31-39.
56. Passarotti AM, Sweeney JA, Pavuluri MN. Fronto-limbic dysfunction in mania pre-treatment and persistent amygdala over-activity post-treatment in pediatric bipolar disorder. Psychopharmacology 2011; 216: 485-499.
57. Heng S, Song AW, Sim K. White matter abnormalities in bipolar disorder: insights from diffusion tensor imaging studies. J Neural Transm 2010; 117: 639-654.
58. Yeh PH, Zhu HT, Nicoletti MA, Hatch JP, Brambilla P, Soares JC. Structural equation modeling and principal component analysis of grey matter volumes in major depressive and bipolar disorders: differences in latent volumetric structure. Psychiatry Res 2010; 184: 177-185.
59. Pompei F, Dima D, Rubia K, Kumari V, Frangou S. Dissociable functional connectivity changes during the Stroop task relating to risk, resilience and disease expression in bipolar disorder. Neuroimage 2011; 57: 576-582.
60. Strakowski SM, Adler CM, DelBello MP. Volumetric MRI studies of mood disorders: do they distinguish unipolar and bipolar disorder? Bipolar Disord 2002; 4: 80-88.
61. Hajek T, Gunde E, Slaney C et al. Striatal volumes in affected and unaffected relatives of bipolar patients - high-risk study. J Psychiatr Res 2009; 43: 724-729.
62. Levitt JJ, Westin CF, Nestor PG et al. Shape of caudate nucleus and its cognitive correlates in neuroleptic-naive schizotypal personality disorder. Biol Psychiatry 2004; 55: 177-184.
63. Stein JL, Hibar DP, Madsen SK et al. Discovery and replication of dopamine-related gene effects on caudate volume in young and elderly populations (N = 1198) using genome-wide search. Mol Psychiatry 2011; 16: 927-937.
64. Bertolino A, Fazio L, Di Giorgio A et al. Genetically determined interaction between the dopamine transporter and the D(2) receptor on prefronto-striatal activity and volume in humans. J Neurosci 2009; 29: 1224-1234.
65. Woodward ND, Zald DH, Ding ZH et al. Cerebral morphology and dopamine D(2)/D(3) receptor distribution in humans: a combined (18)F fallypride and voxel-based morphometry study. Neuroimage 2009; 46: 31-38.
66. Stelzel C, Basten U, Montag C, Reuter M, Fiebach CJ. Frontostriatal involvement in task switching depends on genetic differences in D2 receptor density. J Neurosci 2010; 30: 14205-14212.
67. Markett S, Montag C, Walter NT, Plieger T, Reuter M. On the molecular genetics of flexibility: the case of task-switching, inhibitory control and genetic variants. Cogn Affect Behav Neurosci 2011; 11: 644-651.
68. Tan HY, Chen AG, Kolachana B et al. Effective connectivity of AKT1-mediated dopaminergic working memory networks and pharmacogenetics of anti-dopaminergic treatment. Brain 2012; 135: 1436-1445.
69. Pinsonneault JK, Han DD, Burdick KE et al. Dopamine transporter gene variant affecting expression in human brain is associated with bipolar disorder. Neuropsychopharmacology 2011; 36: 1644-1655.
70. Zhan L, Kerr JR, Lafuente MJ et al. Altered expression and coregulation of dopamine signalling genes in schizophrenia and bipolar disorder. Neuropathol Appl Neurobiol 2011; 37: 206-219.
71. Kozicky J, Torres IJ, Bond DJ, Lam RW, Lakshmi LN. Comparison of neuropsychological effects of adjunctive risperidone or quetiapine in euthymic patients with bipolar I disorder. Int Clin Psychopharmacol 2012; 91: 12-20.
72. Torrent C, Martinez-Aran A, Daban C et al. Effects of atypical antipsychotics on neurocognition in euthymic bipolar patients. Comprehen Psychiatry 2011; 52: 613-622.
73. Hwang J, Lyoo IK, Dager SR et al. Basal ganglia shape alterations in bipolar disorder. Am J Psychiatry 2006; 163: 276-285.
74. Lang DJ, Kopala LC, Vandorpe RA et al. An MRI study of basal ganglia volumes in first-episode schizophrenia patients treated with risperidone. Am J Psychiatry 2001; 158: 625-631.
75. Dazzan P, Morgan KD, Orr K et al. Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the AE SOP study. Neuropsychopharmacology 2005; 30: 765-774.
76. Tauscher-Wisniewski S, Tauscher J, Christensen BK, Mikulis DJ, Zipursky RB. Volumetric MRI measurement of caudate nuclei in antipsychotic-nalve patients suffering from a first episode of psychosis. J Psychiatr Res 2005; 39: 365-370.
77. Glenthoj A, Glenthoj BY, Mackeprang T et al. Basal ganglia volumes in drug-naive first-episode schizophrenia patients before and after short-tenn treatment with either a typical or an atypical antipsychotic drug. Psychiatry Res 2007; 154: 199-208.
78. Massana G, Salgado-Pineda P, Junque C et al. Volume changes in grey matter in first-episode neuroleptic-naive schizophrenic patients treated with risperidone. J Clin Psychopharmacol 2005; 25: 111-117.
79. Chakos MH, Lieberman JA, Bilder RM et al. Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. Am J Psychiatry 1994; 151: 1430-1436.
80. Ebdrup BH, Skimminge A, Rasmussen H et al. Progressive striatal and hippocampal volume loss in initially antipsychotic-naive, first-episode schizophrenia patients treated with quetiapine: relationship to dose and symptoms. Int J Neuropsychopharmacol 2011; 14: 69-82.
81. Yatham LN, Lyoo IK, Liddle P et al. A magnetic resonance imaging study of mood stabilizer- and neuroleptic-naïve first-episode mania. Bipolar Disord 2007; 9: 693-697.
82. Périco CA-M, Duran FLS, Zanetti MV et al. A population-based morphometric MRI study in patients with first-episode psychotic bipolar disorder: comparison with geographically matched healthy controls and major depressive disorder subjects. Bipolar Disord 2011; 13: 28-40.
83. Lewandowski KE, Cohen BM, Ongur D. Evolution of neuropsychological dysfunction during the course of schizophrenia and bipolar disorder. Psychol Med 2011; 41: 225-241.
84. Kozicky J, Ha TH, Torres IJ, Bond DJ, Lam RW, Lakshmi LN. Executive function deficits and morphological brain changes in patients with bipolar I disorder following recovery from a first manic episode. Bipolar Disord 2012; 14 (Suppl. 1): 47.